Hormonal Abnormalities

Hormonal abnormalities are disruptions in the reproductive endocrine system that impair follicle development, ovulation, luteal function, or early pregnancy support. The hormones most frequently evaluated in reproductive medicine include FSH, LH, estradiol, progesterone, prolactin, TSH, and AMH. Each operates within a tightly regulated feedback network. A disorder in one axis typically propagates through others, which is why isolated single-hormone testing outside cycle context misses the clinical picture.1

The FSH and LH axis governs follicular recruitment and the ovulatory trigger. Chronically elevated FSH signals diminished ovarian reserve; tonically elevated LH is a hallmark of PCOS. Estradiol and progesterone govern the proliferative and secretory phases of the endometrial cycle respectively. When progesterone production is insufficient in the luteal phase, implantation is compromised even when ovulation occurred. This is the clinical picture of luteal phase deficiency.

Two additional axes deserve direct attention. TSH outside the optimal range for conception, even within standard laboratory normal limits, is associated with reduced fertility and increased miscarriage risk.2 Elevated prolactin disrupts the hypothalamic-pituitary axis, suppresses LH and FSH pulsatility, and can prevent ovulation entirely; this is hyperprolactinemia.3 AMH reflects the pool of recruitable follicles; low AMH indicates diminished ovarian reserve and may signal diminished ovarian reserve (DOR) or, in severe reduction before age 40, premature ovarian insufficiency (POI).4

RRM clinicians characterize hormonal abnormalities as signs of an underlying condition rather than endpoints in themselves. The question is not simply whether a value is out of range, but why. Identifying root causes, whether hypothyroidism, hyperprolactinemia, ovulatory dysfunction, or metabolic disruption, allows directed evaluation and targeted support rather than bypass of the failing system.

Cited in this entry

  1. The importance of fertility awareness in the assessment of a woman's health: a review. Linacre Q. https://rrmacademy.org/library/importance-of-fertility-awareness-in-the-assessment-of-a-womans-health-recivoft5wcrnk2ic/
  2. Orouji Jokar T et al. Higher TSH Levels Within the Normal Range Are Associated With Unexplained Infertility. J Clin Endocrinol Metab. 2017. Journal of Clinical Endocrinology and Metabolism. https://rrmacademy.org/library/higher-tsh-levels-within-the-normal-range-are-associated-with-unexplained-infert-recfswcfajl43swbh/
  3. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism. https://pubmed.ncbi.nlm.nih.gov/21296991/
  4. Yin WW, Huang CC, Chen YR, Yu DQ, Jin M, Feng C. The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis. BMC Endocrine Disorders. 2022. BMC Endocrine Disorders. https://pubmed.ncbi.nlm.nih.gov/35698127/

This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.